{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:29:32Z","timestamp":1795109372885,"version":"4.10.3"},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Chromatography"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A novel MS\u2010based analytical method for simultaneous analysis of the antiviral drugs acyclovir, its metabolite 9\u2010carboxymethoxymethylguanine, ganciclovir, and penciclovir in human serum is described. These antiviral drugs are active against herpes virus infections. Acyclovir and penciclovir are regarded as safe and effective medicines with mild side effects such as headache and gastrointestinal discomfort, and ganciclovir is regarded as more toxic and is known to cause, for example, bone marrow suppression. Acyclovir\u2019s main metabolite 9\u2010carboxymethoxymethylguanine is a presumptive neurotoxin and should be monitored in patients with impaired renal function or in cases with neurotoxic symptoms. A sample was prepared using protein precipitation with 1% formic acid in methanol containing isotopically labeled internal standard. Chromatographic separation on a biphenyl column and mass spectrometric detection were performed in multiple reaction monitoring (MRM) mode on a Xevo TQ\u2010S micro with ESI in positive ion mode, within 3\u2009min. Inter\u2010day assay accuracies for the quality controls varied between 95 and 104% and intra\u2010day assay between 93 and 105%. Inter\u2010day and intra\u2010day assay imprecision for the quality controls ranged between 1.4 and 4.2% and 1.7 and 6.5% respectively. The lower limit of quantification for all four substances was 0.156\u2009\u03bcmol\/L. It is an accurate and reproducible method for therapeutic drug monitoring.<\/jats:p>","DOI":"10.1002\/bmc.5315","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:43:14Z","timestamp":1641256994000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Rapid determination of acyclovir, its main metabolite 9\u2010carboxymethoxymethylguanine, ganciclovir, and penciclovir in human serum using LC\u2013MS\/MS"],"prefix":"10.1002","volume":"36","author":[{"given":"Andreas","family":"\u00c4rlemalm","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacology and Department of Biomedical and Clinical Sciences Link\u00f6ping University  Link\u00f6ping Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9061-9808","authenticated-orcid":false,"given":"Anders","family":"Helld\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Department of Biomedical and Clinical Sciences Link\u00f6ping University  Link\u00f6ping Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Karlsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Department of Biomedical and Clinical Sciences Link\u00f6ping University  Link\u00f6ping Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7806-6040","authenticated-orcid":false,"given":"Bj\u00f6rn","family":"Carlsson","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology and Department of Biomedical and Clinical Sciences Link\u00f6ping University  Link\u00f6ping Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.201600131"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198702263160912"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/151.2.362"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2014.09.001"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13464"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.792"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2008.04.022"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.02.005"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90059-6"},{"key":"e_1_2_6_11_1","unstructured":"EMA. (2012).Guideline on bioanalytical method validation. European medicines agency Committee for Medicinal Products for human use. Retrived fromhttps:\/\/www.ema.europa.eu\/en\/documnts\/scientific-guideline-bioanalytical-method-validation_en.pdf"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10010077"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2010.12.033"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl067"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg119"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2010.010176"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2016.1172209"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2008.01.046"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2018.1487866"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz357"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000925"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000598"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac020361s"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-207694"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2018.03.052"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.07.002"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4194"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200402000-00014"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2018.06.040"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(96)00424-0"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.202100241"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12343"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.1192"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000164512.99703.ad"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2006.10.053"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2009.01.042"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.03269.x"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113119"}],"container-title":["Biomedical Chromatography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bmc.5315","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bmc.5315","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bmc.5315","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:55:30Z","timestamp":1760043330000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/bmc.5315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.1002\/bmc.5315"],"URL":"https:\/\/doi.org\/10.1002\/bmc.5315","archive":["Portico"],"relation":{},"ISSN":["0269-3879","1099-0801"],"issn-type":[{"value":"0269-3879","type":"print"},{"value":"1099-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"assertion":[{"value":"2021-11-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e5315"}}